AIIMS Jammu partners 4baseCare to host Precision Oncology Expert Meet

New Delhi:  AIIMS Jammu, in collaboration with 4baseCare, an Illumina Accelerator Company, that offers cutting-edge precision oncology solutions using advanced genomics and digital health technology, hosted the Precision Oncology Expert Meet (POEM-2025) on February 3, 2025.

The event, held at the Convention Centre, AIIMS Jammu, brought together leading oncologists, scientists, and healthcare experts to discuss the latest advancements in genomics-driven personalized patient care.

The event was led by Prof. (Dr.) Shakti Kumar Gupta, Executive Director & CEO of AIIMS Jammu, alongside Mr. Hitesh Goswami, Founder & CEO of 4baseCare, and Dr. Poonam Sharma, Associate Professor & Head, Dept. of Pathology, AIIMS Vijaypur, Jammu. Under their leadership, the conference underscored the urgent need for genomic testing, AI-driven diagnostics, and interdisciplinary collaborations to reshape cancer treatment in India.

Commenting on the event, Hitesh Goswami, CEO and Co-Founder, 4baseCare, said, “The recent inauguration of AIIMS Jammu’s Centre for Advanced Genomics & Precision Medicine, followed by POEM-2025, marks a significant milestone in India’s commitment to precision-driven, patient-centric oncology. As India moves towards a future where every cancer patient receives the right treatment at the right time, events like POEM-2025 set the stage for scientific breakthroughs to become clinical realities.” 

POEM-2025 hosted a series of panel discussions, case-based studies, and expert insights focused on leveraging advanced technology for better patient outcomes.

Experts emphasized the importance of data-sharing and multidisciplinary approaches to ensure accurate and effective cancer treatments.

Global speakers, including Dr. Catherine Sia Cheng Teh (Makati Medical Center, Philippines) and Dr. Necy Saguisag Juat (LINCS, Philippines), highlighted the growing role of international cooperation in precision medicine. Leaders shared groundbreaking insights on the evolving role of CAR-T therapy, biomarker-driven treatments, and next-gen immunotherapies.

Specialized discussions on tumor-specific precision medicine applications showcased real-world cases, demonstrating how genomic testing can drive more accurate, effective, and less toxic treatments.

Hitesh Goswami, CEO 4baseCare, discussed the soon to be launched- OncoTwin Insights, a groundbreaking AI-powered platform that is poised to transform cancer care. This innovative solution redefines how cancer treatments are personalized by integrating cutting-edge artificial intelligence, machine learning, and real-world clinical data.

The event reinforced the transformative potential of precision medicine in revolutionizing cancer care in India. It focused on expanding access to genomic testing & targeted therapies, building a bridge between clinical research and real-world application and fostering collaboration between academia, industry, and global oncology experts

POEM will be an annual event that will serve as a standard blueprint for the future—where data-driven, personalized cancer care becomes the standard, not the exception.